Departamento de Psiquiatria - FM/MPS

O Departamento de Psiquiatria da Faculdade de Medicina da Universidade de São Paulo (FMUSP) abrange as áreas de Graduação, Internato, Residência Médica, Pós-Graduação lato sensu e Pós-Graduação stricto sensu, bem como estágios de curta e longa duração para profissionais médicos e de áreas afins. Na graduação, responde por um módulo de Psiquiatria na disciplina de Bases Fisiológicas da Clínica Médica e pelas disciplinas de Bases Humanísticas da Medicina, Psicologia Médica e Psiquiatria Clínica.

Além de atuar nas áreas de ensino e assistência, tem alta produtividade científica na FMUSP, exercendo liderança nacional de pesquisas básica e clínica em áreas de transtornos do humor, transtornos de ansiedade, esquizofrenia, psiquiatria geriátrica, genética e epidemiologia, além de liderar grupos nacionais de pesquisa, como o Consórcio Brasileiro de Pesquisa dos Transtornos do Espectro Obsessivo-Compulsivo (C-TOC).



Recent Submissions

  1. Sociodemographic and clinical characteristics of people with oldest older age bipolar disorder in a global sample: Results from the global aging and geriatric experiments in bipolar disorder project

    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v.39, n.2, article ID e6073, 11p, 2024

    Objects: Studies of older age bipolar disorder (OABD) have mostly focused on ""younger old"" individuals. Little is known about the oldest OABD (OOABD) individuals aged >= 70 years old. The Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) project provides an opportunity to eva...

  2. Networks of Neurodevelopmental Traits, Socioenvironmental Factors, Emotional Dysregulation in Childhood, and Depressive Symptoms Across Development in Two UK Cohorts

    AMERICAN JOURNAL OF PSYCHIATRY, v.180, n.10, p.755-765, 2023

    Objective: Previous population-based studies have identified associations between childhood neurodevelopmental traits and depression in childhood, adolescence, and young adulthood. However, neurodevelopmental traits are highly correlated with each other, which could confound associations when tra...

  3. Unravelling the landscape of <i>Cannabis</i> craving pharmacological treatments: a PRISMA-guided review of evidence

    INTERNATIONAL REVIEW OF PSYCHIATRY, v.35, n.5-6, Special Issue, p.434-449, 2023

    Currently, few treatments are available for craving in general, and none of them have received approval for cannabis craving. The objective of this review is to evaluate existing studies analysing treatments for cannabis craving and explore novel treatment possibilities for these patients. The st...

  4. Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder A Systematic Review and Meta-Analysis

    JAMA PSYCHIATRY, v.81, n.2, p.157-166, 2024

    Importance: Stimulants (methylphenidate and amphetamines) are often prescribed at unlicensed doses for adults with attention-deficit/hyperactivity disorder (ADHD). Whether dose escalation beyond US Food and Drug Administration recommendations is associated with positive risk benefits is unclear.O...

  5. Dissipating the fog: Cognitive trajectories and risk factors 1 year after COVID-19 hospitalization

    ALZHEIMERS & DEMENTIA, v.19, n.9, p.3771-3782, 2023

    Introduction: Cognitive impairment is common after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, associations between post-hospital discharge risk factors and cognitive trajectories have not been explored. Methods: A total of 1105 adults (mean age SD 64.9 9.9 ye...

  6. Is self-reported 7-day point prevalence abstinence an useful measure for smoking cessation effectiveness among individuals with mental disorders?

    INTERNATIONAL REVIEW OF PSYCHIATRY, v.35, n.5-6, Special Issue, p.468-474, 2023

    Smoking rates among individuals with mental disorders are higher compared to general population. We aimed to investigate the effectiveness of a smoking cessation treatment among individuals with and without mental disorders. Self-report 7-day point prevalence was used to assess abstinence status ...

  7. Balance and Gait Associations With Cognitive Impairment and Dementia in Individuals With Down Syndrome

    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, v.37, n.4, p.349-356, 2023

    Background: Atypical aging in Down syndrome (DS) is associated with neuropathological characteristics consistent with Alzheimer disease. Gait abnormalities have been shown to be associated with an increased risk of dementia for the general population. The aim of this study was to determine whethe...

  8. Self-reported bruxism in patients with post-traumatic stress disorder

    CLINICAL ORAL INVESTIGATIONS, v.28, n.2, article ID 152, 10p, 2024

    Objective The present study aimed to investigate the association between self-reported awake/sleep bruxism, and orofacial pain with post-traumatic stress disorder (PTSD). Methods A case-control study with a convenience sample was designed. Participants were recruited from a university-based Traum...

  9. Deviations from a typical development of the cerebellum in youth are associated with psychopathology, executive functions and educational outcomes

    PSYCHOLOGICAL MEDICINE, v.53, n.12, p.5698-5708, 2023

    Background Understanding deviations from typical brain development is a promising approach to comprehend pathophysiology in childhood and adolescence. We investigated if cerebellar volumes different than expected for age and sex could predict psychopathology, executive functions and academic achi...

  10. An Evaluation of Item Harmonization Strategies Between Assessment Tools of Psychopathology in Children and Adolescents

    ASSESSMENT, v.31, n.2, p.502-517, 2024

    Data aggregation in mental health is complicated by using different questionnaires, and little is known about the impact of item harmonization strategies on measurement precision. Therefore, we aimed to assess the impact of various item harmonization strategies for a target and proxy questionnair...